Act II Global Acquisition Corp. (ACTTU), announced the pricing of their $261 million SPAC IPO tonight and the units are expected to begin trading tomorrow, April 26th, under the symbol Nasdaq: ACTTU.
There was a modest up-size to $261 million from $250 million, so now Act II can presumably exercise a full over-allotment to bring the total gross proceeds to just a hair over $300 million (Hennessy IV and Trine used a similar strategy).
Act II is being led by Irwin D. Simon, as Executive Chairman of the Board and John Carroll, as CEO and Director, and will be focusing on the “Better-For-You” sector within consumer packaged goods, consumables and hospitality.
Total SPAC deal count for 2019 year-to-date is now 18 with $4.043 billion in gross proceeds raised. The offering is expected to close on or about April 30, 2019.
Congratulations to all.
Cantor acted as sole book-running manager.
Ellenoff Grossman & Schole LLP and Kirkland & Ellis LLP, were Issuer’s Counsel and Underwriter’s Counsel, respectively.
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs NYSE president says IPO proceeds fall...
InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...
Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...
Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...
The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...